Hogan Lovells has advised Definium Therapeutics, Inc. Definium Therapeutics, Inc. (Nasdaq: DFTX), a late-stage clinical biopharmaceutical company formerly known as Mind Medicine, has completed an upsized...
Definium Therapeutics Completes $805 Million Upsized Public Offering
Perspective Therapeutics Completes US$175 Million Equity Securities Offering
Hogan Lovells has advised Perspective Therapeutics. Davis Polk has advised the representatives of the underwriters. Perspective Therapeutics, Inc. has completed a US$175 million underwritten registered offering...
MindMed Completes US$259 Million Public Offering
Hogan Lovells has advised Mind Medicine (MindMed) Inc. Mind Medicine (MindMed) Inc., a late-stage clinical biopharmaceutical company focused on developing product candidates for brain health disorders,...
Perspective Therapeutics’ $80 Million Shares Offering
Hogan Lovells advised Perspective Therapeutics on the deal. Perspective Therapeutics (NYSE AMERICAN: CATX) has completed an underwritten offering of 51,515,880 shares of its common stock at...
Perspective Therapeutics’ $69 Million Shares Offering and $20.8 Million Private Placement
Hogan Lovells advised Perspective Therapeutics on a series of strategic transactions. Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX) has completed a series of strategic transactions with Lantheus Holdings (NASDAQ:...